Sales 2024 by Business Segment

Sales 2024 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Pharmaceutical Products

          

Specialty & Primary Care

1.13B 1.2B 1.26B 1.37B 1.51B

Total Assets

1.62B 1.62B 1.83B 2.16B 2.18B

EBITDA

421M 422M 418M 467M 524M

Operating Income

349M 344M 312M 388M 427M

Pharmaceutical Sector for Rare Diseases

319M 384M 596M 715M 834M

Total Assets

849M 908M 1.83B 1.8B 2.6B

EBITDA

148M 180M 255M 302M 341M

Operating Income

120M 147M 126M 170M 212M

Total Assets

241M 290M 337M 254M 355M

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

United States of America

128M 182M 268M 323M 396M

Italy

271M 263M 275M 313M 333M

Other International

201M 204M 229M 266M 283M

Total Assets

1.94B 1.97B 2.81B 3.01B 3.64B

CAPEX

-132M -87.36M -96.4M -29.69M -36.65M

Spain

83.82M 120M 143M 165M 214M

France

144M 152M 169M 180M 175M

Other Eastern European

91.98M 112M 129M 150M 168M

Other Western European

91.12M 104M 137M 152M 164M

Germany

136M 153M 168M 151M 161M

Russia, Other CIS Countries and Ukraine

100M 99.6M 132M 141M 151M

Turkey

79.19M 70.31M 74.34M 97.52M 133M

Portugal

42.72M 45.43M 53.46M 60.2M 67.18M

North Africa

41.25M 35.9M 37.66M 40.22M 45.74M

Asia and Oceania

- - - - 27.91M

Europe Excluding Italy

15.24M 17.14M 14.35M 15.21M 16.34M

America (U.S.A. Excluded)

4.58M 4.76M 4.72M 5.54M 6.01M

Africa

1.5M 1.68M 2.58M 1.33M 601K

Australasia

16.88M 14.52M 16.99M 21.53M -